Eribuline Baxter 0
As listed in the register: Eribuline Baxter 0,44 mg/ml oplossing voor injectie
0,44 mg/ml · oplossing voor injectie
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Eribulinemesilaat
- Made by
- Baxter Holding B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
Bulgaria6 matching products
- Eribulin ADVZ 0.44 mg/ml · solution for injection
- Eribulin EVER Pharma 0.44 mg/ml · solution for injection
- Eribulin STADA 0,44 mg/ml · solution for injection
- Eribulin Tillomed Eribulin Tillomed 0.44 mg/ml · solution for injection
- Eribulin Zentiva 0.44 mg/ml · solution for injection
- Sclarint 0.44 mg/ml · solution for injection
European UnionNo exact match for this strength and form
Spain12 matching products
- HALAVEN 0,44 mg/ml · solución inyectable2 makers
- ERIBULINA ADVANZ PHARMA 0,44 mg/ml · solución inyectable
- ERIBULINA BAXTER 0,44 mg/ml · solución inyectable
- ERIBULINA CTTQ 0,44 mg/ml · solución inyectable
- ERIBULINA EVER PHARMA 0,44 mg/ml · solución inyectable
- ERIBULINA GLENMARK 0,44 mg/ml · solución inyectable
- ERIBULINA HIKMA 0,44 mg/ml · solución inyectable
- ERIBULINA STADA 0,44 mg/ml · solución inyectable
CanadaNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Baxter Holding B.V. |
|---|---|
| Active substance | Eribulinemesilaat |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 0,44 mg/ml |
| Form | oplossing voor injectie |
| Classification | L01XX41 · Cancer treatments and immune-system medicines |
| Route | intraveneus gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Eribuline Baxter 0,44 mg/ml oplossing voor injectie |
| RVG | EU/1/24/1819 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.